Aegis is pleased to offer its latest innovation, BioDetect™, designed to enhance healthcare providers’ abilities to identify patient specimens that have been substituted using synthetic urine.
BioDetect™ is a method designed to identify patient specimens that have been substituted using synthetic urine. Through the identification of unique markers expected in human urine, healthcare providers will have greater insight into patients' medication adherence.
Patients may be at risk for non-prescription drug use or medication diversion. To mask these behaviors, specimens may be substituted with synthetic urine.
Urine substitution occurs when:
- Someone wants to appear as if they are taking a prescribed drug
- Someone wants to hide or mask drugs not prescribed
Aegis has identified unique markers that are expected to be detected in routinely analyzed human urine. Our goal is to provide clinicians greater insight regarding potential substitution to mitigate risk and make treatment decisions with greater confidence.
BioDetect is an innovative solution included in testing of all urine specimens. Every Laboratory Report will have Aegis BioDetect™ results as either Expected or Not Expected.
If you are a Healthcare Provider seeking information please contact your Regional Sales Manager or Client Services team at 1.800.533.7052 or email Client.Services@aegislabs.com